bioRxivBioinformaticsPreprint
Batch Effect Correction to Enhance Utility of a Publicly Available ALS Proteomics Dataset
Grace Cooper, Inez Oh, Philip PayneiD, Zachary B. AbramsiD, Timothy Miller
Abstract
Large, publicly available databases of patient data have been successful in identifying associations between neurodegenerative diseases and biological features that might otherwise go unnoticed. The Answer ALS Consortium is one such database that has generated a rich repository of multi-omic data from people with amyotrophic lateral sclerosis (ALS). However, large studies can suffer from batch effects that obscure genuine biological signal and prevent experiment reproducibility. In this study, we identified a batch effect in the Answer ALS 1-2 proteomic dataset (508 samples x 3,643 proteins) and corrected the effect using both the internal controls provided by Answer ALS and the batch effect-correction algorithm (BECA) ComBat. We identified a batch effect in the Answer ALS Dataset 1-2 proteomic dataset that, uncorrected, may obscure biology. Proteins MOS and H4 were outliers of expression in the dataset that correlated with the batch effect. Removing MOS and H4 did not correct the effect fully but did reveal new principal component (PC) contributing proteins related to motor neurons and potentially ALS: AINX, NFL, and NFM. The batch differential controls (BDCs) provided by Answer ALS were used to correct samples in their respective batches. ComBat, a well-characterized BECA, was applied to the dataset both before (ComBat-BDC) and after (BDC-ComBat) correction with the BDCs. BDC-ComBat was the only method that successfully reduced batch effect across the entire dataset. This method also preserved four of the top six PC-contributing proteins from the original dataset, including three neuronal proteins, suggesting that the corrected dataset recapitulates biology as well as the variability of the original dataset. Altogether, we produced a version of the Answer ALS proteomic dataset (354 samples by 3,641 proteins) with globally reduced batch effect and protein-level reduced batch effect. This version of the dataset recapitulates the individual protein variability and important neuronal proteins of the original. We also created a workflow for identifying and correcting batch effects that can be applied to other large data repositories.
- organism: human
- assay: proteomics
- research focus: batch correction / integration
- research focus: benchmarking
- research focus: database / resource
- research focus: software / tool
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mapping the circulating proteome across neurodegeneration: A harmonized, consortium-scale framework for uncovering molecular pathophysiology
Caitlin A. Finney, Lijun An, … Artur Shvetcov·bioRxiv·Dec 12, 2025
- Network Analysis of the Cerebrospinal Fluid Proteome Reveals Shared and Unique Differences Between Sporadic and Familial Forms of Amyotrophic Lateral Sclerosis
Adam N. Trautwig, Edward J. Fox, … Jonathan D. Glass·Molecular NeurodegenerationPeer-reviewed·May 15, 2025
- TDP-43-stratified single-cell proteomic profiling of postmortem human spinal motor neurons reveals protein dynamics in amyotrophic lateral sclerosis
A. J. Guise, S. A. Misal, … R. T. Kelly·bioRxiv·Jun 8, 2023
- Analysis of circulating protein aggregates reveals pathological hallmarks of amyotrophic lateral sclerosis
Rocco Adiutori, Fabìola Puentes, … Andrea Malaspina·bioRxiv·Apr 30, 2020
- A validated antibody toolbox for ALS research
Riham Ayoubi, Emma J. MacDougall, … Carl Laflamme·bioRxiv·Sep 14, 2025
- Non-linear gene sets for digital biomarkers of amyotrophic lateral sclerosis
Keiko Imamura, Ayako Nagahashi, … Haruhisa Inoue·bioRxiv·Dec 20, 2025